We therefore hypothesize that these compounds, which induce apoptosis in prostate cancer cells by increasing DR5 expression, are not clearly selective for androgen-dependent and androgen-independent prostate cancer cells. This evidence concerns the gene TNFRSF10B and prostate carcinoma.